Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.65 USD | +5.61% | +6.60% | -37.15% |
06-14 | Transcript : Aurinia Pharmaceuticals Inc. - Shareholder/Analyst Call | |
06-07 | ILJIN SNT Co Provides Information to Shareholders of Aurinia Pharmaceuticals | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.15% | 806M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- SVB Leerink Adjusts Aurinia Pharmaceuticals' Price Target to $35 from $28, Keeps Outperform Rating